Grading Evidence for Laboratory Test Studies Beyond Diagnostic Accuracy: Application to Prognostic Testing.
BACKGROUND
Evidence-based guideline development requires transparent methodology for gathering, synthesizing and grading the quality and strength of evidence behind recommendations. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) project has addressed diagnostic test use in many of their publications. Most of the work has been directed at diagnostic tests and no consensus has been reached for prognostic biomarkers.
The GRADE system for rating the quality of evidence and the strength of a recommendation is described. The application of GRADE to diagnostic testing is discussed and a description of application to prognostic testing is detailed. Some strengths and limitations of the GRADE process in relation to clinical laboratory testing are presented.


CONCLUSIONS
The GRADE system is applicable to clinical laboratory testing and if correctly applied should improve the reporting of recommendations for clinical laboratory tests by standardising the style of recommendation and by encouraging transparent reporting of the actual guideline process.
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.
Andrew C
AC
Don-Wauchope
Department of Clinical Epidemiology and Biostatistics, McMaster University , Hamilton, Ontario, Canada.
Pasqualina L
PL
Santaguida
Clin Chim Acta. 2014 Jan 1;427:49-57
24076255
BMC Health Serv Res. 2004 Dec 22;4(1):38
15615589
Ann Intern Med. 2006 Mar 21;144(6):427-37
16549855
Ann Intern Med. 2011 Oct 18;155(8):529-36
22007046
Heart Fail Rev. 2014 Aug;19(4):439-51
24969534
J Clin Epidemiol. 2011 Dec;64(12):1311-6
21802902
Evid Based Med. 2008 Dec;13(6):162-3
19043023
J Clin Epidemiol. 2011 Apr;64(4):407-15
21247734
Clin Chem. 2003 Jan;49(1):7-18
12507954
Heart Fail Rev. 2014 Aug;19(4):507-19
25052418
J Clin Epidemiol. 2013 Jul;66(7):719-25
23312392
J Clin Epidemiol. 2011 Apr;64(4):401-6
21208779
J Clin Epidemiol. 2011 Apr;64(4):395-400
21194891
Allergy. 2011 May;66(5):588-95
21241318
PLoS Med. 2013;10(2):e1001380
23393429
Heart Fail Rev. 2014 Aug;19(4):471-505
24986335
Heart Fail Rev. 2014 Aug;19(4):541-51
25052419
J Gen Intern Med. 2012 Jun;27 Suppl 1:S47-55
22648675
PLoS Med. 2014 Jul 08;11(7):e1001671
25003600
BMJ. 2009 Feb 23;338:b375
19237405
J Clin Epidemiol. 2014 Jul;67(7):760-8
24725643
BMJ. 2008 Apr 26;336(7650):924-6
18436948
AMIA Annu Symp Proc. 2006;:359-63
17238363
J Clin Epidemiol. 2011 Dec;64(12):1294-302
21803546
J Clin Epidemiol. 2013 Jul;66(7):736-42; quiz 742.e1-5
23623694
J Gen Intern Med. 2012 Jun;27 Suppl 1:S67-75
22648677
Implement Sci. 2011 Jun 10;6:62
21663655
PLoS Med. 2012;9(5):1-12
22629234
Allergy. 2009 May;64(5):669-77
19210357
Heart Fail Rev. 2014 Aug;19(4):413-9
24953975
Heart Fail Rev. 2014 Aug;19(4):421-38
24957908
Heart Fail Rev. 2014 Aug;19(4):521-40
25120174
BMJ. 2008 May 17;336(7653):1106-10
18483053
J Clin Epidemiol. 2011 Dec;64(12):1283-93
21839614
J Clin Epidemiol. 2008 Jun;61(6):552-60
18471659
J Gen Intern Med. 2012 Jun;27 Suppl 1:S33-8
22648673
Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1048-55
15968029
J Gen Intern Med. 2012 Jun;27 Suppl 1:S4-10
22648669
J Gen Intern Med. 2012 Jun;27 Suppl 1:S11-9
22648670
Heart Fail Rev. 2014 Aug;19(4):453-70
25062653
Ann Intern Med. 2013 Feb 19;158(4):280-6
23420236
BMC Med Res Methodol. 2003 Nov 10;3:25
14606960
Syst Rev. 2013 Sep 05;2:71
24007720
J Clin Epidemiol. 2011 Dec;64(12):1277-82
21802904
J Clin Epidemiol. 2011 Dec;64(12):1303-10
21802903
J Clin Epidemiol. 2011 Apr;64(4):383-94
21195583